Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Inflammatix, a pioneering molecular diagnostics company delivering precision medicine at the point of care, announced findings from a new study...
Inflammatix, a pioneering molecular diagnostics company delivering precision medicine at the point of care, today announced a $32 million Series C...
Inflammatix, a pioneering molecular diagnostics company, announced today an agreement with the Biomedical Advanced Research and Development Authority ...
Inflammatix, a molecular diagnostics company that is reimagining diagnostics, announced today that it has received the American Association for...
Inflammatix announced today that it has been named a finalist for the American Association for Clinical Chemistry's (AACC) Disruptive Technology...
Inflammatix today announced that it will present findings from two studies demonstrating the ability of its HostDx™ Fever test to distinguish...
Inflammatix announced today that it has been named a finalist in Fast Company's 2018 World Changing Ideas Awards for its novel HostDx™ tests, which...
Inflammatix announced findings from a new study published today in Nature Communications that suggest that diagnosing and determining who will likely ...
Inflammatix, a molecular diagnostics company that is developing rapid tests that read the immune system to improve disease diagnosis, today announced ...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.